ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Operating margin (%)

Fuso Pharmaceutical Industries,Ltd. (4538)

Market cap
¥19.4B
P/E ratio
13.5x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating margin (%) YoY (%)
Mar 31, 20264.2-37.91%
Mar 31, 20256.8+92.43%
Mar 31, 20243.5-18.03%
Mar 31, 20234.3+11.55%
Mar 31, 20223.9-18.79%
Mar 31, 20214.8+121.67%
Mar 31, 20202.2-21.32%
Mar 31, 20192.7+57.42%
Mar 31, 20181.7+23.98%
Mar 31, 20171.4+116.74%
Mar 31, 20160.6-61.77%
Mar 31, 20151.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat